Jesus Esquivel, MD, FACS
Medical Director, International Oncology Initiatives & National Director for HIPEC Research
Eastern Regional Medical Center
"My overall goal for all cancer patients is to make sure they have the right diagnosis and receive the right treatment by the right healthcare provider."
- Jesus Esquivel, MD, FACS
- Universidad Autonoma de Tamaulipas, Tampico, Tamaulipas, Mexico
Internship / Residency
- General Surgery Residency – The New York Hospital of Queens, Flushing, NY
- Surgical Internship – Washington Hospital Center, Washington, DC
- Gastrointestinal Surgical Oncology Fellowship – Washington Cancer Institute, Washington, DC
- American Board of Surgery
Practicing Since: 1999
A Fellow of the American College of Surgeons, Dr. Jesus Esquivel is a surgical oncologist as well as Medical Director, International Oncology Initiatives and National Director for HIPEC Research for CTCA.
Prior to joining CTCA, Dr. Esquivel spent nearly eight years as Director of the Peritoneal Surface Malignancies Program at St. Agnes Health Care Hospital in Baltimore, MD. He was a Cancer Liaison Physician with the American College of Surgeons from 2005 to 2008. Prior to then, he spent five years in general and oncology surgery in Washington, DC.
Dr. Esquivel earned a medical degree from the Universidad Autonoma de Tamaulipas in Mexico. After completing a medical internship in Mexico City, he moved to the United States and completed a surgical internship at Washington Hospital Center in Washington, DC.
He then completed a six-year general surgery residency at The New York Hospital of Queens in Flushing, NY, where he was Chief Surgical Resident in the final year. After his residency, Dr. Esquivel completed a two-year gastrointestinal surgical oncology fellowship at the Washington Cancer Institute in Washington, DC, under Dr. Paul Sugarbaker.
Dr. Esquivel is also an Assistant Professor of Gynecologic Oncology at Johns Hopkins School of Medicine in Baltimore for the last seven years. He is currently an adjunct member of the United States Military Cancer Institute.
Dr. Esquivel specializes in combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of gastrointestinal tumors that have disseminated throughout the abdominal cavity. His primary interest is in appendiceal and colorectal tumors.
He has contributed to over 60 peer-reviewed publications, book chapters and scientific exhibits, and has presented at nearly 30 workshops. Some of Dr. Esquivel's published works include:
Dr. Esquivel's clinical research is oriented at minimally invasive treatment of pseudomyxoma peritonei and at identifying selection criteria for cytoreduction and HIPEC in patients with colorectal cancer.
Dr. Esquivel founded the American Society of Peritoneal Surface Malignancies (ASPSM) that now has more than 172 members from 20 countries. He is also a member of the American College of Surgeons Oncology Group, the Society of Surgical Oncology and the American Society of Clinical Oncology.
In his free time, Dr. Esquivel enjoys long distance running.